Kategori: PRNews

Tan will lead the positioning of Cerecin’s pipeline of highly innovative neurotherapeutics SINGAPORE, Oct. 24, 2018 /PRNewswire/ — Brain health-focused pharmaceutical company Cerecin, today announced the appointment of Cheryl Tan…

Most Powerful Sequencer to Date SHENZHEN, China, Oct. 28, 2018 /PRNewswire/ — MGI, a subsidiary of BGI Group, introduced its newest model of genetic sequencer, MGISEQ-T7, which vastly improves speed,…

SUZHOU, China, Oct. 23, 2018 /PRNewswire/ — CStone Pharmaceuticals (“CStone”) today announced that the United States Food and Drug Administration (FDA) has recently granted approval to the company’s Investigational New…

FLORENCE, Italy, Oct. 25, 2018 /PRNewswire/ — Did you know that Botticelli‘s Birth of Venus was the first painting after the fall of the Roman Empire to feature a completely…

-Forum held to share the idea of inclusivity in diversity with teachers and students BEIJING, Oct. 25, 2018 /PRNewswire/ — Dr Lui Che-woo, Chairman of K. Wah Group and Director…

ADELAIDE, Australia, Oct. 26, 2018 /PRNewswire/ — Mayne Pharma Group Limited (“Mayne Pharma”) (ASX: MYX) has acquired the FDA approved halobetasol propionate foam 0.05% for an investment of up to…

BEIJING, Oct. 24, 2018 /PRNewswire/ — China Biologic Products Holdings, Inc. (NASDAQ: CBPO) (“China Biologic” or the “Company”), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that…

SHANGHAI, Oct. 25, 2018 /PRNewswire/ — Fullerton Healthcare Corporation Limited (“Fullerton Health” or the “Group”), a leading vertically integrated healthcare platform in Asia Pacific, announced today that Fullerton Health China…

SEOUL, South Korea, Oct. 24, 2018 /PRNewswire/ — The Korea Ginseng Association reported that the annual October Korean Ginseng festivals, total 16 of them this year, are successfully being held…

TAIPEI, Taiwan, Oct. 24, 2018, /PRNewswire/ — TaiwanJ Pharmaceuticals, a specialty pharmaceutical company dedicated to the development and commercialization of small molecules for unmet medical needs, recently announced the results…